GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Respiratorius AB (XSAT:RESP) » Definitions » Total Equity

Respiratorius AB (XSAT:RESP) Total Equity : kr30.10 Mil (As of Dec. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Respiratorius AB Total Equity?

Respiratorius AB's total equity for the quarter that ended in Dec. 2024 was kr30.10 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Respiratorius AB Total Equity Historical Data

The historical data trend for Respiratorius AB's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Respiratorius AB Total Equity Chart

Respiratorius AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 29.28 56.81 34.33 26.50 30.10

Respiratorius AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Apr22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 26.50 24.74 24.85 32.18 30.10

Respiratorius AB Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Respiratorius AB's Total Equity for the fiscal year that ended in Dec. 2024 is calculated as

Total Equity=Total Assets(Q: Dec. 2024 )-Total Liabilities(Q: Dec. 2024 )
=31.015-0.92
=30.10

Respiratorius AB's Total Equity for the quarter that ended in Dec. 2024 is calculated as

Total Equity=Total Assets(Q: Dec. 2024 )-Total Liabilities(Q: Dec. 2024 )
=31.015-0.92
=30.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Respiratorius AB Total Equity Related Terms

Thank you for viewing the detailed overview of Respiratorius AB's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Respiratorius AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Respiratorius AB (XSAT:RESP) » Definitions » Total Equity
Comparable Companies
XSAT:DBP B OSTO:CMOTEC B OSTO:STABL OSTO:NANECH OSTO:FLUI OSTO:COMBI OSTO:LPGO OSTO:MODTX XSAT:PHAL OSTO:LIDDS VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
Scheelevagen 2, Medicon Village, Lund, SWE, 223 81
Website
https://www.respiratorius.com
Respiratorius AB develops pharmaceutical drugs to treat the common diseases namely Cancer, Chronic Obstructive Pulmonary Disease (COPD), and asthma as well as better methods for diagnosing cardiovascular diseases. The company's drug candidates includes RCD405, VAL001, RESP2000, RESP3000, RESP9000, and RESP1000.

Respiratorius AB Headlines

No Headlines